- FASTA Sequence
- PDBx/mmCIF Format
- PDBx/mmCIF Format (gz)
- BinaryCIF Format (gz)
- Legacy PDB Format
- Legacy PDB Format (gz)
- PDBML/XML Format (gz)
- Structure Factors (CIF)
- Structure Factors (CIF - gz)
- Validation Full (PDF - gz)
- Validation (XML - gz)
- Validation (CIF - gz)
- Validation 2fo-fc coefficients (CIF - gz)
- Validation fo-fc coefficients (CIF - gz)
- Biological Assembly 1 (CIF - gz)
- Biological Assembly 2 (CIF - gz)
- Biological Assembly 1 (PDB - gz)
- Biological Assembly 2 (PDB - gz)
486: 11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE
486 is a Ligand Of Interest in 1NHZ designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1NHZ_486_A_800 | 60% | 1% | 0.152 | 0.936 | 3.52 | 4.22 | 18 | 23 | 2 | 0 | 100% | 1 |
| 5UC3_486_A_801 | 71% | 50% | 0.149 | 0.969 | 0.74 | 1.16 | 1 | 5 | 1 | 0 | 100% | 1 |
| 3H52_486_D_2 | 68% | 31% | 0.15 | 0.961 | 0.81 | 1.9 | 1 | 11 | 18 | 0 | 100% | 1 |
| 2W8Y_486_A_1000 | 65% | 39% | 0.118 | 0.919 | 0.89 | 1.47 | 1 | 6 | 5 | 0 | 100% | 1 |
| 5UC1_486_B_801 | 59% | 54% | 0.173 | 0.956 | 0.83 | 0.93 | - | 1 | 2 | 0 | 100% | 1 |
| 3QT0_486_A_4 | 58% | 1% | 0.163 | 0.943 | 2 | 5.8 | 3 | 13 | 11 | 0 | 100% | 1 |
- RCSB PDB is hosted by
- RCSB PDB is a member of
- RCSB Partners
- Nucleic Acid Knowledgebase
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729.